PMID- 33098618 OWN - NLM STAT- MEDLINE DCOM- 20210818 LR - 20210818 IS - 1552-4930 (Electronic) IS - 1552-4922 (Linking) VI - 99 IP - 3 DP - 2021 Mar TI - Comprehensive Phenotyping of Dendritic Cells in Cancer Patients by Flow Cytometry. PG - 218-230 LID - 10.1002/cyto.a.24245 [doi] AB - Dendritic cells (DCs) play a crucial role in the complex interplay between tumor cells and the immune system. During the elimination phase of cancer immunoediting, immunostimulatory DCs are critical for the control of tumor growth. During the escape phase, regulatory DCs sustain tumor tolerance and contribute to the development of the immunosuppressive tumor microenvironment that characterizes this phase. Moreover, increasing evidence indicates that DCs are also critical for the success of cancer immunotherapy. Hence, there is increasing need to fully characterize DC subsets and their activatory/inhibitory profile in cancer patients. In this review, we describe the role played by different DC subsets in the different phases of cancer immunoediting, the function exerted by different activatory and inhibitory molecules expressed on DC surface, and the cytokines produced by distinct DC subsets, in order to provide an overview on the DC features that may be useful to be assessed when dealing with the flow cytometric characterization of DCs in cancer patients. (c) 2020 International Society for Advancement of Cytometry. CI - (c) 2020 International Society for Advancement of Cytometry. FAU - Carenza, Claudia AU - Carenza C AD - Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy. AD - Unit of Clinical and Experimental Immunology, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy. FAU - Franzese, Sara AU - Franzese S AD - Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy. AD - Unit of Clinical and Experimental Immunology, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy. FAU - Calcaterra, Francesca AU - Calcaterra F AD - Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy. AD - Unit of Clinical and Experimental Immunology, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy. FAU - Mavilio, Domenico AU - Mavilio D AD - Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy. AD - Unit of Clinical and Experimental Immunology, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy. FAU - Della Bella, Silvia AU - Della Bella S AUID- ORCID: 0000-0003-0818-5049 AD - Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy. AD - Unit of Clinical and Experimental Immunology, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20201111 PL - United States TA - Cytometry A JT - Cytometry. Part A : the journal of the International Society for Analytical Cytology JID - 101235694 SB - IM MH - *Dendritic Cells MH - Flow Cytometry MH - Humans MH - Immune Tolerance MH - Immunotherapy MH - *Neoplasms MH - Tumor Microenvironment OTO - NOTNLM OT - cancer immunoediting OT - conventional DCs (cDCs) OT - costimulatory molecules OT - flow cytometry OT - human DCs OT - immune checkpoints OT - peripheral blood DCs (PBDCs) OT - plasmacytoid DCs (pDCs) OT - tumor-associated DCs (TADCs) EDAT- 2020/10/25 06:00 MHDA- 2021/08/19 06:00 CRDT- 2020/10/24 12:08 PHST- 2020/08/27 00:00 [received] PHST- 2020/10/08 00:00 [revised] PHST- 2020/10/19 00:00 [accepted] PHST- 2020/10/25 06:00 [pubmed] PHST- 2021/08/19 06:00 [medline] PHST- 2020/10/24 12:08 [entrez] AID - 10.1002/cyto.a.24245 [doi] PST - ppublish SO - Cytometry A. 2021 Mar;99(3):218-230. doi: 10.1002/cyto.a.24245. Epub 2020 Nov 11.